bms204352 has been researched along with clamikalant in 1 studies
| Studies (bms204352) | Trials (bms204352) | Recent Studies (post-2010) (bms204352) | Studies (clamikalant) | Trials (clamikalant) | Recent Studies (post-2010) (clamikalant) |
|---|---|---|---|---|---|
| 49 | 1 | 12 | 32 | 0 | 3 |
| Protein | Taxonomy | bms204352 (IC50) | clamikalant (IC50) |
|---|---|---|---|
| ATP-binding cassette sub-family C member 9 | Homo sapiens (human) | 4.3 | |
| ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | 8.2 | |
| ATP-sensitive inward rectifier potassium channel 11 | Homo sapiens (human) | 6.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carroll, WA; Coghlan, MJ; Gopalakrishnan, M | 1 |
1 review(s) available for bms204352 and clamikalant
| Article | Year |
|---|---|
Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress.
Topics: Adenosine Triphosphate; Angina Pectoris; Arrhythmias, Cardiac; Asthma; Calcium; Ion Channel Gating; Myocardial Ischemia; Potassium Channel Blockers; Potassium Channels; Urinary Incontinence | 2001 |